Advanced Health Intelligence Ltd (ASX: AHI) (NASDAQ:AHI) (“AHI” or the “Company”) would like to inform shareholders that the Company will be expanding the current biometric assessment suite with
ISS, Glass Lewis and Egan-Jones Endorse Proposed Transaction Stockholders are Encouraged to Vote FOR the Value-Maximizing Transaction Before the Electronic Proxy Voting Deadline of 11:59 P.M. Eastern Time on